# Sensor Augmented Pump Therapy Versus Multiple Daily Injection Therapy

> **NCT01921322** · NA · COMPLETED · sponsor: **Medtronic MiniMed, Inc.** · enrollment: 118 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DEVICE:** Pump
- **OTHER:** CGMS Gold

## Key facts

- **NCT ID:** NCT01921322
- **Lead sponsor:** Medtronic MiniMed, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2015-05
- **Final completion:** 2015-05
- **Target enrollment:** 118 (ACTUAL)
- **Last updated:** 2017-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01921322

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01921322, "Sensor Augmented Pump Therapy Versus Multiple Daily Injection Therapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01921322. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*